(Q39511361)

12 September 2017

title

Clinical trial of intra-arterial polychemotherapy in the treatment of carcinoma of the oral cavity (English)

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

6 November 2022

author name string

C. Curioni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81254

6 November 2022

G. Quadu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81254

6 November 2022

language of work or name

1 reference

1 August 1978

1 reference

full work available at URL

12 September 2017

https://api.elsevier.com/content/article/PII:S0301050378800915?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

https://api.elsevier.com/content/article/PII:S0301050378800915?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

Journal of maxillofacial surgery

6 November 2022

published in

1 reference

12 September 2017

volume

6

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

207-216

1 reference

Treatment of advanced cancer of the head and neck

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Chemotherapy of cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

The role of chemotherapy in the management of cancer of the head and neck: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Relations between histology, TNM-Category and results of treatment with methotrexate-bleomycin-combination in squamous cell carcinomas of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Chemotherapy of neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Regional chemotherapy with combined drugs in cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Systemic chemotherapy of advanced head and neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Irradiation treatment of inoperable squamous cell carcinomas of the oral cavity and oropharynx after partial synchronisation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Proliferative Potential of Out-of-cycle Leukaemic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

The variability of individual tolerance to methotrexate in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Anticoagulants in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

The value of adriamycin in overcoming resistance to methotrexate in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

The time factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

[Clinical trials with adriamycin in leukemia and solid tumors].

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

A reappraisal of intra-arterial chemotherapy.Results obtained in 145 patients with head and neck cancer treated during 1963-1966 with intra-arterial chemotherapy followed by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Regional arterial chemotherapy for advanced carcinoma of the head and neck. A ten-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Intra-Arterial Infusion with Methotrexate in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Bleomycin in malignant tumors of head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0503%2878%2980091-5

7 January 2021

Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin

4

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo

6 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

Intermittent dose schedule of mitomycin C (NSC-26980) in solid tumors

6 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

Investigations on pharmacologic induction of partial synchronization of tumor cell proliferation: its relevance for cytostatic therapy

6 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

Radiation therapy and chemotherapy

6 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0301-0503(78)80091-5

6 November 2022

Identifiers

1 reference

12 September 2017

1 reference